Extended-Release Naltrexone Opiod Treatment at Jail Re-Entry

Trial Profile

Extended-Release Naltrexone Opiod Treatment at Jail Re-Entry

Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Naltrexone (Primary) ; Methadone
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Acronyms XOR
  • Most Recent Events

    • 14 Jun 2017 Planned End Date changed from 1 May 2018 to 1 Jan 2021.
    • 14 Jun 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2021.
    • 27 Oct 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top